SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: China Heparin Industry, 2013-2017

[January 17, 2014]

Research and Markets: China Heparin Industry, 2013-2017

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/5fcqgf/research_and) has announced the addition of the "Research and Development Forecast of China Heparin Industry, 2013-2017" report to their offering.

The global heparin API manufacturing enterprises are mainly concentrated in the China, Europe and the US; the supply volume of heparin APIs of these three regions accounts for more than 95% of the global supply volume; the supply volume of heparin AIPs in China ranks the world first and accounts for more than 50% of the global supply volume.

According to the statistics of China Customs, since 2007, the export amount of China's heparin products has been rising greatly for a fourth consecutive year; in 2011, under the affection of depressed international market and the improvement of heparin export standards, the export volume and amount of China's heparin products had the obvious decline; in the year of 2012 and 2013, the decline trend of the export volume of heparin products slowed, but the export amount still had a certain decline because of the price.

At present, Chna has totally 22 heparin API manufacturing enterprises that have passed the approval of China Food and Drug Administration, but there are less than 10 manufacturers that have engaged in the actual production; in addition, there are 500 to 1,000 companies of heparin crude products, which form the high domestic heparin API production concentration ratio; the production capacity is mainly concentrated in the top five manufacturing enterprises of heparin products with about 80% of market shares totally now.


Key Topics Covered

1. Industry Overview of Heparin

1.1 Definition and Classification

1.2 Industrial Chain

2. China's Heparin Industry Development Environment

2.1 China's Economic Development Environment

2.2 Related Policies and Standards

3. Development Overview of China's Heparin API (Active Pharmaceutical Ingredient) Industry

3.1 Development Overview of Global Heparin Industry

3.2 Status Quo of China's Heparin API Industry

3.3 Imports and Exports

3.4 Competitive Pattern

4. Development Overview of China's Heparin Upstream and Downstream Industry

4.1 Upstream Industry

4.2 Downstream Industry

5. China's Major Heparin Manufacturing Enterprises

6. Investment Analysis of Heparin Industry

6.1 Investment Risks

6.2 Investment Suggestions

7. Development Trends and Forecast of Heparin Industry

7.1 Development Trends

7.2 Market Scale Forecast of Heparin Products

Companies Mentioned

- Changzhou Qianhong Bio-pharma

- Development Prospects

- Hebei Changshan Biochemical Pharmaceutical

- Nanjing Jianyou Biochemical Pharmaceutical

- Qingdao Jiulong Biomedicine

- Shenzhen Hepalink Pharmaceutical (Hepalink)

- Tianjin Chase Sun Pharmaceutical

- Yantai Dongcheng Biochemicals

For more information visit http://www.researchandmarkets.com/research/5fcqgf/research_and

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy